Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zoetis Inc. Director's Dealing 2022

Jul 11, 2022

29945_dirs_2022-07-11_1f909cd0-ff94-4af6-ab07-b9c04f3f811a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2022-07-07

Reporting Person: PECK KRISTIN C (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-07-07 Common Stock M 311 $30.89 Acquired 40054 Direct
2022-07-07 Common Stock S 311 $180 Disposed 39743 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-07-07 Stock Option $ M 311 Disposed Common Stock (311.0) Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.

F2: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

F3: 311 options granted March 4, 2014 at an exercise price of $30.89 per option.

F4: Each option vests on the third anniversary of the date of grant.

F5: Each option expires on the tenth anniversary of the date of grant.

F6: 4,725 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.